He's estimating the pharmacy conglomerate will post a non-GAAP (adjusted) net profit of $1.71 per share for fiscal 2025, which is well below the $2.85 consensus pundit forecast for this year. Yet ...
and prompted it to implement a high-profile 10-for-1 stock split. In the wake of the company's better-than-expected fiscal third-quarter results last month, WallStreet is getting more bullish ...